Literature DB >> 18383332

Early lung disease in young children with primary ciliary dyskinesia.

David E Brown1, Jessica E Pittman, Margaret W Leigh, Lynn Fordham, Stephanie D Davis.   

Abstract

Primary ciliary dyskinesia (PCD) is an autosomal recessive disease in which ciliary dysfunction leads to chronic lung, sinus, and middle ear disease. PCD is often not diagnosed until late childhood due to its presumed rarity and the technical expertise necessary for diagnosis; as such, little is known about lung disease in young children with PCD. We report on 3 young children with PCD who had evidence of lung disease on infant pulmonary function testing, bronchoscopy, and/or computed tomography (CT) of the chest before 3 years of age. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18383332     DOI: 10.1002/ppul.20792

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  27 in total

Review 1.  Primary ciliary dyskinesia, an orphan disease.

Authors:  Mieke Boon; Mark Jorissen; Marijke Proesmans; Kris De Boeck
Journal:  Eur J Pediatr       Date:  2012-07-10       Impact factor: 3.183

Review 2.  Primary ciliary dyskinesia: improving the diagnostic approach.

Authors:  Margaret W Leigh; Maimoona A Zariwala; Michael R Knowles
Journal:  Curr Opin Pediatr       Date:  2009-06       Impact factor: 2.856

3.  Standardizing nasal nitric oxide measurement as a test for primary ciliary dyskinesia.

Authors:  Margaret W Leigh; Milan J Hazucha; Kunal K Chawla; Brock R Baker; Adam J Shapiro; David E Brown; Lisa M Lavange; Bethany J Horton; Bahjat Qaqish; Johnny L Carson; Stephanie D Davis; Sharon D Dell; Thomas W Ferkol; Jeffrey J Atkinson; Kenneth N Olivier; Scott D Sagel; Margaret Rosenfeld; Carlos Milla; Hye-Seung Lee; Jeffrey Krischer; Maimoona A Zariwala; Michael R Knowles
Journal:  Ann Am Thorac Soc       Date:  2013-12

4.  Infant pulmonary function testing: overview of technology and practical considerations--new current procedural terminology codes effective 2010.

Authors:  Burton L Lesnick; Stephanie D Davis
Journal:  Chest       Date:  2011-05       Impact factor: 9.410

5.  Clinical features of childhood primary ciliary dyskinesia by genotype and ultrastructural phenotype.

Authors:  Stephanie D Davis; Thomas W Ferkol; Margaret Rosenfeld; Hye-Seung Lee; Sharon D Dell; Scott D Sagel; Carlos Milla; Maimoona A Zariwala; Jessica E Pittman; Adam J Shapiro; Johnny L Carson; Jeffrey P Krischer; Milan J Hazucha; Matthew L Cooper; Michael R Knowles; Margaret W Leigh
Journal:  Am J Respir Crit Care Med       Date:  2015-02-01       Impact factor: 21.405

6.  Proof of Concept: Very Rapid Tidal Breathing Nasal Nitric Oxide Sampling Discriminates Primary Ciliary Dyskinesia from Healthy Subjects.

Authors:  Mathias G Holgersen; June K Marthin; Kim G Nielsen
Journal:  Lung       Date:  2019-02-14       Impact factor: 2.584

Review 7.  Primary ciliary dyskinesia.

Authors:  Jason Lobo; Maimoona A Zariwala; Peadar G Noone
Journal:  Semin Respir Crit Care Med       Date:  2015-03-31       Impact factor: 3.119

8.  Primary Ciliary Dyskinesia (PCD): A genetic disorder of motile cilia.

Authors:  Margaret W Leigh; Amjad Horani; BreAnna Kinghorn; Michael G O'Connor; Maimoona A Zariwala; Michael R Knowles
Journal:  Transl Sci Rare Dis       Date:  2019-07-04

9.  Elastase Exocytosis by Airway Neutrophils Is Associated with Early Lung Damage in Children with Cystic Fibrosis.

Authors:  Camilla Margaroli; Luke W Garratt; Hamed Horati; A Susanne Dittrich; Timothy Rosenow; Samuel T Montgomery; Dario L Frey; Milton R Brown; Carsten Schultz; Lokesh Guglani; Anthony Kicic; Limin Peng; Bob J Scholte; Marcus A Mall; Hettie M Janssens; Stephen M Stick; Rabindra Tirouvanziam
Journal:  Am J Respir Crit Care Med       Date:  2019-04-01       Impact factor: 21.405

Review 10.  Primary Ciliary Dyskinesia: An Update on New Diagnostic Modalities and Review of the Literature.

Authors:  Rizwana Popatia; Kenan Haver; Alicia Casey
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2014-06-01       Impact factor: 1.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.